FDA import alert status
Jiangsu Longliqi Bioscience Co Ltd.
China · appears on 2 FDA import alerts
2
Red-list alerts
0
Green-list alerts
0
Yellow-list alerts
China
Country
2022-10-13
Latest indexed date
What this means
As published on the official FDA import alert list, this firm appears on 2 red lists. A red-list firm is subject to Detention Without Physical Examination (DWPE): FDA can detain its shipments at the border automatically, without sampling. The burden shifts to the importer to prove the goods are not violative.
Import alert status changes over time. Import Alert Radar re-checks the official FDA source every day; the entries below reflect the latest refresh (2026-09-04 UTC).
New · one-time pilot
Need a dated supplier record now?
Get a source-linked Supplier Evidence Snapshot for Jiangsu Longliqi Bioscience Co Ltd.: current red / green-list status, every matching FDA import alert, dates, official links and the dataset timestamp — prepared for your supplier file.
Informational evidence record, not legal advice or an FDA/FSVP certification.
Do you buy from Jiangsu Longliqi Bioscience Co Ltd.?
Put this supplier on watch: we re-check the official FDA import alert list daily and email you the day Jiangsu Longliqi Bioscience Co Ltd. is added to a red list — or removed from one — so a detained shipment never catches you by surprise.
Red-list entries
- Import Alert 66-41RED · 07/30/2010
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Import Alert 66-79RED · 10/13/2022
Detention Without Physical Examination of Drugs From Foreign Establishments Refusing FDA Inspection
Is Jiangsu Longliqi Bioscience Co Ltd. in your supply chain? Alert me when this supplier's FDA status changes — $19/mo